Article thumbnail

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya

By Elizabeth A Juma, Charles O Obonyo, Willis S Akhwale and Bernhards R Ogutu
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2635380
Provided by: PubMed Central

Suggested articles

Citations

  1. (2008). A: The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in Tanzania. Malar J
  2. (2006). Adam I: Efficacy of artemether-lumefantrine (Co-Artesiane®) suspension in the treatment of uncomplicated P. falciparum malaria among children under 5 years in eastern Sudan. Trop J Pharm Res
  3. (2008). Akhwale WS, Snow RW: The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J
  4. (2000). Alteri E: An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug. Trans R Soc Trop Med Hyg
  5. (2004). Artemether-lumefantrine for uncomplicated malaria: a systematic review. Trop Med Int Health
  6. (2003). CC: The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg
  7. (2005). CJM: Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet
  8. (2005). CR: The role of sequential administration of sulfadoxine-pyrimethamine following quinine in the treatment of severe falciparum malaria in children. Trop Med Int Health
  9. (2005). Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg
  10. (2006). Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6–59 months old in Ghana. Trop Med Int Health
  11. (2006). G: Population dynamics of malaria vectors in western Kenya highlands.
  12. (2004). Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg
  13. (2003). Kouakou YG: Comparative study of artemether suspension monotherapy in 2 different regimes with a combination suspension containing artemether-lumefantrine for the treatment of simple childhood malaria in Abidjan, Ivory Coast
  14. (1999). Looareesuwan S: Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug resistant Plasmodium falciparum malaria. Am J Trop Med Hyg
  15. (2007). Nzila A: Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin Pharmacother
  16. Organization: Antimalarial Drug Combination Therapy. I n Report of a WHO Technical Consultation Volume 35. Geneva, World Health Organization .
  17. Organization: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria Volume 50. Geneva, World Health Organization :1-68.
  18. (2008). Pagnoni F: Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Saharan Africa. Malar J
  19. (2005). Quashie N: Comparative efficacy of antimalarial drugs including ACTs in treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop
  20. (2006). Sipilanyambe N: Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Co-artesiane®) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Malar J
  21. (2007). Snow RW: Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
  22. (2008). Snow RW: Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Trop Med Int Health
  23. (2008). Snow RW: Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
  24. (2002). Some E, Taylor WR: Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet
  25. (2003). ter Kuile F, Oloo AJ: Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double blind, placebo-controlled trial. Trans R Soc Trop Med Hyg
  26. (2004). The process of changing national malaria treatment policy: lessons from countrylevel studies. Health Policy Plan
  27. (1999). Viriyakosol S: Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.